Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1442999/000166357721000273/abti10q.htm
October 2023
October 2023
September 2023
June 2023
October 2022
September 2022
July 2022
May 2022
May 2022
December 2021
Cover - shares | 3 Months Ended | |
---|---|---|
Dec. 31, 2020 | Mar. 17, 2021 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Dec. 31, 2020 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2021 | |
Current Fiscal Year End Date | --09-30 | |
Entity File Number | 333-156091 | |
Entity Registrant Name | Alterola Biotech Inc. | |
Entity Central Index Key | 0001442999 | |
Entity Incorporation, State or Country Code | NV | |
Entity Current Reporting Status | No | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 754,280,000 |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1442999/000166357721000273/abti10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Alterola Biotech Inc..
Alterola Biotech Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Alterola Biotech Inc. provided additional information to their SEC Filing as exhibits
Ticker: ABTI
CIK: 1442999
Form Type: 10-Q Quarterly Report
Accession Number: 0001663577-21-000273
Submitted to the SEC: Fri May 28 2021 2:28:12 PM EST
Accepted by the SEC: Fri May 28 2021
Period: Thursday, December 31, 2020
Industry: Metal Mining